Literature DB >> 17917609

Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.

Egle Corrado1, Manfredi Rizzo, Ida Muratori, Giuseppe Coppola, Salvatore Novo.   

Abstract

OBJECTIVE: Limited information exists regarding the association between markers of inflammation, such as high-sensitivity C-reactive protein (hs-CRP) and fibrinogen, and adverse events in postmenopausal women with subclinical atherosclerosis. Therefore, we investigated the prognostic impact of traditional risk factors and inflammation on adverse cardiac events in women with asymptomatic carotid lesions.
DESIGN: We studied 250 postmenopausal women who were free of cardiovascular disease. Traditional cardiovascular risk factors were investigated, and laboratory analysis included measurement of plasma lipids, fibrinogen, and hs-CRP. The early phases of carotid atherosclerosis were assessed by B-mode ultrasonography. Women were asked about symptoms or a previous history of coronary artery disease and were followed for a period of 5 years.
RESULTS: We found that the increment in age (in quintiles) was significantly associated with higher incidence of current smokers (P = 0.0286), hypertension (P = 0.0230), family history of coronary artery disease (P = 0.0216), dyslipidemia (P = 0.0330), and higher levels of fibrinogen (P = 0.0158). Moreover, older women had a higher prevalence of carotid lesions (P < 0.0001). After the follow-up, cardio- and cerebrovascular events were registered in 22% of the women. Using multivariate analysis, we observed that older age (odds ratio [OR], 1.7; 95% CI, 1.3-2.2; P < 0.0001), fibrinogen (OR, 1.6; 95% CI, 1.2-2.0; P < 0.0001), the presence of carotid lesions (OR, 2.0; 95% CI, 1.4-3.0; P = 0.0002), and hs-CRP (OR, 1.3; 95% CI, 1.2-2.0; P = 0.0175) were predictors of adverse events during the follow-up.
CONCLUSIONS: Adverse events occurred more frequently in women with higher levels of fibrinogen and hs-CRP. The significance of these results requires confirmation in other studies, but they may have important implications for screening subjects at risk for cardiovascular disease and identifying candidates for anti-inflammatory therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17917609     DOI: 10.1097/gme.0b013e31812e6b60

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  4 in total

1.  Stroke in Women: What is Different?

Authors:  Dara G Jamieson; Maryna Skliut
Journal:  Curr Atheroscler Rep       Date:  2010-07       Impact factor: 5.113

2.  Total cholesterol and LDL levels decrease before rheumatoid arthritis.

Authors:  Elena Myasoedova; Cynthia S Crowson; Hilal Maradit Kremers; Patrick D Fitz-Gibbon; Terry M Therneau; Sherine E Gabriel
Journal:  Ann Rheum Dis       Date:  2009-10-23       Impact factor: 19.103

3.  Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: a cross-sectional study.

Authors:  Carlo Domenico Maida; Sonya Vasto; Domenico Di Raimondo; Alessandra Casuccio; Valerio Vassallo; Mario Daidone; Alessandro Del Cuore; Gaetano Pacinella; Anna Cirrincione; Irene Simonetta; Vittoriano Della Corte; Salvatore Rizzica; Giulio Geraci; Antonino Tuttolomondo; Antonio Pinto
Journal:  Aging (Albany NY)       Date:  2020-05-03       Impact factor: 5.682

4.  Relationship between inflammatory markers and new cardiovascular events in patients with acute myocardial infarction who underwent primary angioplasty.

Authors:  Eluisa La Franca; Marco Caruso; Angela Sansone; Rosanna Iacona; Laura Ajello; Dario Mancuso; Fabiana Castellano; Salvatore Novo; Pasquale Assennato
Journal:  Glob J Health Sci       Date:  2013-03-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.